Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma
Clinical trial NCT01316523 · TERMINATED
Trial details
- NCT number
- NCT01316523
- Sponsor
- University of California, Davis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2023-09-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.